Carmen Aguilera-González

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
We have read with great interest the editorial by Beattie and Johnson, discussing the role of subcutaneous furosemide (SCF) as an off-label palliative symptomatic treatment feasible for patients with decompensated advanced heart failure (DAHF), whose preferences led to being attended to in their homes, thus avoiding inappropriate hospitalisations, as(More)
  • 1